Journal rankings · indicator year 2022
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2022
Infectious Diseases journal rankings 2022
243 ranked journals · Subfield in Medicine
Infectious Diseases has 243 ranked journals in 2022. The median journal has an OJR of 0.61, below the world average of 1.00, up 0.01 on 2021; Q1 starts at OJR 1.10. The top three are New England Journal of Medicine, Clinical Microbiology Reviews, and MMWR Morbidity and Mortality Weekly Report.
Ranks and citation indicators: 2022. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2019–2021, the window the 2022 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery1,001
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health310
- Cardiology and Cardiovascular Medicine296
- Oncology245
- Infectious Diseases243
- Epidemiology196
- Neurology176
- Radiology, Nuclear Medicine and Imaging165
- Physiology162
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health147
Show all 42 subfields
- Orthopedics and Sports Medicine123
- Ophthalmology103
- Pediatrics, Perinatology and Child Health101
- Dermatology97
- Obstetrics and Gynecology88
- Hematology83
- Rheumatology65
- Nephrology62
- Reproductive Medicine54
- Complementary and alternative medicine51
- Pharmacology51
- Emergency Medicine43
- Geriatrics and Gerontology38
- Rehabilitation36
- Otorhinolaryngology34
- Pathology and Forensic Medicine29
- Hepatology28
- Immunology and Allergy24
- Critical Care and Intensive Care Medicine23
- Genetics20
- Anesthesiology and Pain Medicine15
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
243 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2021. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2019–2021, the window the 2022 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2019–2021 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2013 to 2022. | Compare |
|---|---|---|---|---|---|---|---|
1New England Journal of MedicineMassachusetts Medical Society · United States | 14.28Q1 | 52.93 8.85 down from 2021 | 3,441 | 42% | — | ||
2Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 8.96Q1 | 30.89 9.64 down from 2021 | 111 | 100% | — | ||
3MMWR Morbidity and Mortality Weekly ReportOACenters for Disease Control and Prevention · United States | 7.69Q1 | 35.51 1.12 down from 2021 | 913 | 100% | — | ||
4The Lancet Regional Health - EuropeOAElsevier BV · United Kingdom | 4.68Q1 | 15.62 11.13 down from 2021 | 257 | 100% | $4,930 | ||
5The Lancet Infectious DiseasesElsevier BV · Netherlands | 4.45Q1 | 26.90 4.95 down from 2021 | 1,199 | 63% | $7,280 | ||
6The Lancet Global HealthOAElsevier BV · Netherlands | 4.21Q1 | 14.25 2.73 down from 2021 | 984 | 100% | $6,680 | ||
7PLoS MedicineOAPublic Library of Science · United States | 3.53Q1 | 14.06 0.71 up from 2021 | 922 | 100% | $6,460 | ||
8Annals of Internal MedicineAmerican College of Physicians · United States | 3.25Q1 | 13.44 1.63 down from 2021 | 1,472 | 17% | — | ||
9EurosurveillanceOAEuropean Centre for Disease Prevention and Control · Sweden | 3.24Q1 | 20.57 1.81 down from 2021 | 660 | 100% | — | ||
10EClinicalMedicineOAElsevier BV · Netherlands | 2.92Q1 | 13.83 0.15 up from 2021 | 1,101 | 100% | $5,780 | ||
11The Lancet MicrobeOAElsevier BV · United Kingdom | 2.90Q1 | 17.27 14.47 down from 2021 | 232 | 100% | $7,280 | ||
12JMIR Public Health and SurveillanceOAJMIR Publications · Canada | 2.54Q1 | 10.03 5.17 down from 2021 | 553 | 100% | $2,800 | ||
13Emerging Microbes & InfectionsOATaylor & Francis · United Kingdom | 2.50Q1 | 15.01 5.03 down from 2021 | 720 | 100% | $2,643 | ||
14npj VaccinesOANature Portfolio · United Kingdom | 2.46Q1 | 10.59 0.36 down from 2021 | 305 | 100% | $3,890 | ||
15Clinical Microbiology and InfectionElsevier BV · United Kingdom | 2.10Q1 | 12.12 0.22 down from 2021 | 1,187 | 100% | $3,780 | ||
16Communications MedicineOANature Portfolio · United Kingdom | 2.08Q1 | 6.38no 2021 value | 61 | 100% | $3,690 | — | |
17VaccinesOAMultidisciplinary Digital Publishing Institute · Switzerland | 2.01Q1 | 9.10 3.04 up from 2021 | 2,560 | 100% | $3,258 | ||
18Journal of Epidemiology and Global HealthOAElsevier BV · Netherlands | 2.01Q1 | 5.06 1.93 down from 2021 | 175 | 100% | $2,690 | ||
19Antiviral ResearchElsevier BV · Netherlands | 1.98Q1 | 9.04 2.65 down from 2021 | 528 | 70% | $4,160 | ||
20Clinical Infectious DiseasesOxford University Press · United States | 1.96Q1 | 10.88 1.68 down from 2021 | 3,853 | 76% | $4,763 | ||
21PLoS PathogensOAPublic Library of Science · United States | 1.91Q1 | 7.50 0.72 down from 2021 | 2,045 | 100% | $3,043 | ||
22Emerging infectious diseasesOACenters for Disease Control and Prevention · United States | 1.88Q1 | 9.36 2.19 down from 2021 | 1,752 | 100% | — | ||
23Journal of Medical VirologyWiley · United States | 1.85Q1 | 13.01 7.00 down from 2021 | 2,113 | 63% | $4,730 | ||
24Journal of Infection and Public HealthOAElsevier BV · Netherlands | 1.77Q1 | 10.21 0.06 up from 2021 | 746 | 100% | $2,310 | ||
25Virus EvolutionOAUniversity of Oxford · United Kingdom | 1.77Q1 | 7.70 1.50 up from 2021 | 259 | 100% | $3,304 | ||
26Reviews in Medical VirologyWiley · United Kingdom | 1.75Q1 | 13.11 0.04 up from 2021 | 266 | 60% | $4,880 | ||
27Diagnostic and Prognostic ResearchOABioMed Central · United Kingdom | 1.74Q1 | 3.89 2.50 down from 2021 | 67 | 100% | $2,790 | ||
28International Journal of Infectious DiseasesOAElsevier BV · Netherlands | 1.73Q1 | 10.07 3.41 down from 2021 | 2,402 | 100% | $2,900 | ||
29Journal of InfectionOAElsevier BV · United Kingdom | 1.65Q1 | 11.62 7.80 down from 2021 | 1,166 | 77% | $4,030 | ||
30Pathogens and ImmunityOACase Western Reserve University · United States | 1.61Q1 | 8.56 3.40 up from 2021 | 51 | 100% | — | ||
31Antimicrobial Resistance and Infection ControlOABioMed Central · United Kingdom | 1.57Q1 | 6.60 1.22 down from 2021 | 565 | 100% | $3,290 | ||
32The Lancet HIVElsevier BV · Netherlands | 1.56Q1 | 10.14 1.87 up from 2021 | 392 | 52% | $7,280 | ||
33InfectionSpringer Science+Business Media · Germany | 1.55Q1 | 8.46 0.08 down from 2021 | 440 | 79% | $4,790 | ||
34Virology JournalOABioMed Central · United Kingdom | 1.53Q1 | 5.90 1.61 down from 2021 | 595 | 100% | $3,290 | ||
35Journal of Clinical MicrobiologyOAAmerican Society for Microbiology · United States | 1.46Q1 | 8.63 0.96 down from 2021 | 1,120 | 100% | — | ||
36The Journal of Infectious DiseasesOxford University Press · United States | 1.43Q1 | 6.57 0.48 down from 2021 | 2,005 | 86% | $4,763 | ||
37Microbiology SpectrumOAAmerican Society for Microbiology · United States | 1.42Q1 | 4.08 6.15 down from 2021 | 677 | 100% | $2,500 | ||
38Virus ResearchOAElsevier BV · Netherlands | 1.41Q1 | 6.00 1.30 down from 2021 | 760 | 61% | $3,010 | ||
39Journal of Microbiology Immunology and InfectionOAElsevier BV · Hong Kong SAR China | 1.39Q1 | 7.59 4.56 down from 2021 | 441 | 100% | $2,000 | ||
40Current Clinical Microbiology ReportsSpringer Science+Business Media · Germany | 1.38Q1 | 6.53 1.91 up from 2021 | 58 | 80% | $4,790 | ||
41VirusesOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.37Q1 | 5.41 1.34 down from 2021 | 5,201 | 100% | $3,137 | ||
42VirulenceOATaylor & Francis · United States | 1.35Q1 | 5.33 0.69 up from 2021 | 397 | 100% | $2,557 | ||
43Expert Review of Anti-infective TherapyTaylor & Francis · United Kingdom | 1.34Q1 | 6.78 0.35 up from 2021 | 395 | 28% | — | ||
44Current HIV/AIDS ReportsSpringer Science+Business Media · United States | 1.32Q1 | 5.39 1.04 down from 2021 | 167 | 82% | $4,190 | ||
45Medical Microbiology and ImmunologySpringer Science+Business Media · Germany | 1.31Q1 | 6.05 1.63 up from 2021 | 141 | 77% | $5,090 | ||
46DiseasesOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.30Q1 | 4.80 0.21 up from 2021 | 195 | 100% | $2,172 | ||
47Journal of Hospital InfectionElsevier BV · United Kingdom | 1.27Q1 | 7.12 2.25 down from 2021 | 916 | 69% | $4,000 | ||
48PathogensOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.25Q1 | 4.35 1.02 down from 2021 | 3,064 | 100% | $2,654 | ||
49MycopathologiaSpringer Science+Business Media · Netherlands | 1.24Q1 | 7.40 2.55 up from 2021 | 256 | 39% | $4,190 | ||
50Journal of General VirologyMicrobiology Society · United Kingdom | 1.23Q1 | 4.51 0.73 down from 2021 | 463 | 58% | — |
Subfields of Medicine, with Infectious Diseases highlighted.
- Surgery1,001
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health310
- Cardiology and Cardiovascular Medicine296
- Oncology245
- Infectious Diseases243
- Epidemiology196
- Neurology176
- Radiology, Nuclear Medicine and Imaging165
- Physiology162
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health147
- Orthopedics and Sports Medicine123
- Ophthalmology103
- Pediatrics, Perinatology and Child Health101
- Dermatology97
- Obstetrics and Gynecology88
- Hematology83
- Rheumatology65
- Nephrology62
- Reproductive Medicine54
- Complementary and alternative medicine51
- Pharmacology51
- Emergency Medicine43
- Geriatrics and Gerontology38
- Rehabilitation36
- Otorhinolaryngology34
- Pathology and Forensic Medicine29
- Hepatology28
- Immunology and Allergy24
- Critical Care and Intensive Care Medicine23
- Genetics20
- Anesthesiology and Pain Medicine15
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2022. Corpus-wide, 89.5% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
64 additional Infectious Diseases journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2019–2021, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2022. Publication window: 2019–2021. How these summaries are calculated
- Ranked journals
- 243
- Window papers (baseline)
- 135,954 +92.4% from indicator year 2019
- Median OJR
- 0.61 -27.2% from indicator year 2019
- Rising journals (2025)
- 48
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2019–2021 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 70 | 73 | 78 | 82 | 86 | 92 | 95 | 101 | 106 | 110 | 118 | 131 | 144 | 162 | 173 | 182 | 189 | 198 | 210 | 217 | 222 | 234 | 243 | 259 | 263 | 258 | |
| Window papers (baseline) | 18,375 | 21,167 | 22,805 | 24,640 | 25,208 | 28,008 | 31,333 | 35,063 | 38,170 | 42,272 | 46,364 | 49,515 | 52,080 | 54,445 | 58,513 | 62,728 | 67,259 | 69,548 | 70,742 | 70,658 | 72,743 | 100,768 | 135,954 | 162,915 | 153,103 | 130,899 | |
| Median OJR | 0.602 | 0.68 | 0.82 | 0.76 | 0.77 | 0.901 | 0.98 | 0.93 | 1.04 | 0.998 | 1.01 | 0.999 | 0.97 | 0.900 | 0.91 | 0.874 | 0.85 | 0.8699 | 0.8696 | 0.83 | 0.80 | 0.597 | 0.61 | 0.64 | 0.70 | 0.75 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.